These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Equivalence of various levothyroxine preparations. Fischer RG; Kibbe AH; Nicholas WC; Sbravati C; Read VH J Fam Pract; 1982 Mar; 14(3):591-3. PubMed ID: 7038029 [No Abstract] [Full Text] [Related]
11. Bioequivalence of levothyroxine preparations: industry sponsorship and academic freedom. Eckert CH JAMA; 1997 Apr; 277(15):1200-1. PubMed ID: 9103338 [No Abstract] [Full Text] [Related]
12. Levothyroxine dosage and the limitations of current bioequivalence standards. Hennessey JV Nat Clin Pract Endocrinol Metab; 2006 Sep; 2(9):474-5. PubMed ID: 16957756 [No Abstract] [Full Text] [Related]
13. New questions regarding bioequivalence of levothyroxine preparations: a clinician's response. Green WL AAPS J; 2005 Mar; 7(1):E54-8. PubMed ID: 16146330 [TBL] [Abstract][Full Text] [Related]
14. Ingestion of large amounts of papaya fruit and impaired effectiveness of levothyroxine therapy. Deiana L; Marini S; Mariotti S Endocr Pract; 2012; 18(1):98-100. PubMed ID: 21856591 [No Abstract] [Full Text] [Related]
16. Are multisource levothyroxine sodium tablets marketed in Egypt interchangeable? Abou-Taleb BA; Bondok M; Nounou MI; Khalafallah N; Khalil S Ann Endocrinol (Paris); 2018 Feb; 79(1):23-29. PubMed ID: 29289332 [TBL] [Abstract][Full Text] [Related]
17. Levothyroxine: therapeutic use and regulatory issues related to bioequivalence. Wartofsky L Expert Opin Pharmacother; 2002 Jun; 3(6):727-32. PubMed ID: 12036412 [TBL] [Abstract][Full Text] [Related]
18. [Primary hypothyroidism: Considerations for a rational use of levothyroxine therapy]. Bros JA; Lluís PG; Cabot GL; Pedragós AC Med Clin (Barc); 2011 Feb; 136(5):207-14. PubMed ID: 19646718 [No Abstract] [Full Text] [Related]
19. [Differences in the effectiveness of levothyroxine preparations]. Wenzel KW; Mehrländer U Dtsch Med Wochenschr; 1987 Jan; 113(2):53-8. PubMed ID: 3322763 [TBL] [Abstract][Full Text] [Related]
20. [Preventable problems in thyroid hormone substitution therapy. The risks of brand change are unpredictable]. MMW Fortschr Med; 2010 Jun; 152(22):46-7. PubMed ID: 20590034 [No Abstract] [Full Text] [Related] [Next] [New Search]